Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracey G Simon
Kathleen E Corey

Showing results (1-10 of 251) with videos related to

Pageof 26
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2019
ReplyTracey G Simon, Kathleen E Corey
Digestive Diseases and Sciences|October 8, 2016
Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of EzetimibeTracey G Simon, Kathleen E Corey, Raymond T Chung, et al.
Gastroenterology|August 10, 2020
Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and FibrosisAshwini Arvind, Stephanie A Osganian, Julia A Sjoquist, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2020
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver diseaseJacqueline B Henson, Tracey G Simon, Alyson Kaplan, et al.
Obesity (Silver Spring, Md.)|July 27, 2017
Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and DysfunctionTracey G Simon, Daniel G Bamira, Raymond T Chung, et al.
Metabolism: Clinical and Experimental|April 23, 2021
Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysisAshwini Arvind, Zoe N Memel, Lisa L Philpotts, et al.
Plos One|October 26, 2017
The MELD-Plus: A generalizable prediction risk score in cirrhosisUri Kartoun, Kathleen E Corey, Tracey G Simon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2019
Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver DiseaseTracey G Simon, Jacqueline Henson, Stephanie Osganian, et al.
Hepatology Communications|November 1, 2017
MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD)Tracey G Simon, Uri Kartoun, Hui Zheng, et al.
Hepatology Communications|January 13, 2021
Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysisZoe N Memel, Ashwini Arvind, Oluwatoba Moninuola, et al.
Pageof 26

Showing results (1-10 of 251) with videos related to

Sort By:
Pageof 26
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2019
ReplyTracey G Simon, Kathleen E Corey
Digestive Diseases and Sciences|October 8, 2016
Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of EzetimibeTracey G Simon, Kathleen E Corey, Raymond T Chung, et al.
Gastroenterology|August 10, 2020
Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and FibrosisAshwini Arvind, Stephanie A Osganian, Julia A Sjoquist, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2020
Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver diseaseJacqueline B Henson, Tracey G Simon, Alyson Kaplan, et al.
Obesity (Silver Spring, Md.)|July 27, 2017
Nonalcoholic Steatohepatitis is Associated with Cardiac Remodeling and DysfunctionTracey G Simon, Daniel G Bamira, Raymond T Chung, et al.
Metabolism: Clinical and Experimental|April 23, 2021
Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysisAshwini Arvind, Zoe N Memel, Lisa L Philpotts, et al.
Plos One|October 26, 2017
The MELD-Plus: A generalizable prediction risk score in cirrhosisUri Kartoun, Kathleen E Corey, Tracey G Simon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2019
Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver DiseaseTracey G Simon, Jacqueline Henson, Stephanie Osganian, et al.
Hepatology Communications|November 1, 2017
MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD)Tracey G Simon, Uri Kartoun, Hui Zheng, et al.
Hepatology Communications|January 13, 2021
Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysisZoe N Memel, Ashwini Arvind, Oluwatoba Moninuola, et al.
Pageof 26